
Dr. Ravi Munver sat down for an interview with CURE to discuss progress in kidney cancer care.

Dr. Ravi Munver sat down for an interview with CURE to discuss progress in kidney cancer care.

I was diagnosed with colon cancer at 17, and while I’ll always be part of the AYA community, turning 40 has shown me the gift of growing older.

CURE spoke with nurse and breast cancer survivor Amanda Davis at the John Theurer Cancer Center.

Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer.

Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team.

Learn how myelodysplastic syndrome treatment has advanced with targeted therapies and anemia management while balancing quality of life for patients.

After receiving a breast cancer diagnosis at 29, Amanda Davis wants other young adults who are patients to know that “brighter days are coming.”

It is very important to let the world know that no matter how healthy you think you are, if you have lungs, you can potentially develop lung cancer.

Kidney cancer care has seen advances over the past few decades, reflecting both improved diagnostic capabilities and less invasive treatment approaches.

The U.S. FDA has granted fast track designation to the investigational therapy MNV-201 for the treatment of myelodysplastic syndrome.

Non-melanoma skin cancer is a common and highly treatable type of cancer that originates in the top layer of the skin, like basal cell carcinoma.

The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.

Many of the choices I've made regarding yard maintenance relate to my hopes to mitigate the risk of more cancer.

A guide for patients to understand HER2-positive breast cancer, treatment options by stage and how to talk with your oncologist.

Among patients with pancreatic cancer, the vaccine ELI-002 7P elicited strong mKRAS-specific T cell responses in approximately 99% of patients.

Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox Chase Cancer Center.

A cancer survivor explains that we must all become involved in trying to bring back cancer research.

Nancee Pronsati discusses a new patient-authored guide for managing ALK-directed treatment side effects in lung cancer and improving quality of life.

Leukemia is a blood cancer that disrupts normal cell production, leading to infection risk, anemia and bleeding, and requiring tailored treatments.

What is the first emotion that comes to mind about your cancer journey? For me, the strong emotion that I choose is shock!

Last week, the American College of Radiation Oncology submitted comments to CMS on the CY 2026 Physician Fee Schedule and Hospital Outpatient PPS.

Diagnosed with multiple myeloma? Our guide explains each stage and treatment, helping you engage confidently with your care team.

The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.

Being diagnosed with a rare cancer like GIST can be overwhelming, highlighting the need for support networks, says Dr. Rosario Ligresti.

I reflect on how my family and friends showed love in different ways during the early days of my chronic cancer diagnosis.

Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for patients with limited options.

For patients with advanced GIST, complete surgical removal of metastases and full response to Gleevec are associated with roughly double the survival time.

Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.

Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.

The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may offer new options for patients.